Health Care

Health Care — White House rejects using federal land for abortion

As officials work on reaching out to convince parents of kids under 5 to get vaccinated, Elmo got his COVID-19 vaccine today

Today in health care, the White House is not on board with an idea pushed by some Democrats to try to allow abortions on federal lands. We’ll also look at what the administration is saying about access to abortion pills.

Welcome to Overnight Health Care, where we’re following the latest moves on policy and news affecting your health. For The Hill, we’re Peter SullivanNathaniel Weixel and Joseph Choi. Someone forward you this newsletter? Subscribe here.

Big ‘ramifications’ to abortion idea, White House says

White House press secretary Karine Jean-Pierre on Tuesday warned that there could be “dangerous ramifications” to providing abortion services on federal lands in the wake of the Supreme Court ruling that struck down Roe v. Wade.

Pressure to do more: The Biden administration has come under pressure from progressives to take tougher actions in response to Roe v. Wade’s overturning, including considering the use of federal land in states opposed to abortion to provide the service. 

But Jean-Pierre said it doing so could put those providing and getting the service at legal and physical risk. 

Calls from progressives: Democrats, including Sen. Elizabeth Warren (Mass.) and Rep. Alexandria Ocasio-Cortez (N.Y.), have called on the Biden administration to use federal land to create places where people can receive abortions in states that restrict them. 

Read more here.

Becerra stops short of lawsuits to shield abortion pills

Health and Human Services Secretary Xavier Becerra on Tuesday stopped short of saying the Biden administration would sue in a bid to stop states from banning abortion pills, saying the details are still being worked out on actions on that front.

“We will certainly assert and defend our legal authorities,” Becerra told reporters at a press conference when asked about filing lawsuits through the Department of Justice. 

“What exactly that translates into depends on what a state tries to do,” he added.  

When pressed by a reporter about conservative states that have already put into effect sweeping abortion bans that include bans on abortion pills, Becerra said the department had to “investigate and then enforce.” 

“We have to make sure we collect the evidence but we are intent on protecting people’s rights under the law,” he said. 

Big picture: Protecting access to abortion pills is seen as one of the main ways that the Biden administration can seek to protect abortion access in conservative states that are enacting bans on the medical procedure. 

Read more here.

TEXAS COURT BLOCKS ENFORCEMENT OF PRE-ROE ABORTION BAN

A Texas court on Tuesday temporarily blocked the state’s long-dormant pre-Roe v. Wade abortion ban that had suddenly been reinstated after Roe was struck down on Friday, a move that will allow some clinics to resume the practice. 

Takeaway: Prior to Friday’s ruling overturning Roe v. Wade, abortion was available in Texas up to six weeks’ gestation. Since then, all abortions in the state have ceased. The injunction will allow abortion up to six weeks of pregnancy to resume at some clinics. 

Read more here.

JUUL SAYS FDA OVERLOOKED KEY DATA IN APPLICATION

E-cigarette company Juul argued in court documents filed on Tuesday that the Food and Drug Administration (FDA) had overlooked a mountain of data that it had included in its application that demonstrated its products’ benefit to public health, and said the decision to ban the product was based on “deeply flawed reasons.” 

Last week, the FDA announced it was banning Juul from marketing and selling it products. Products from the company that are already out on the market would have to be removed, per the agency’s decision.  

Read more here.

Panel favors updating COVID vaccines for omicron

An expert advisory vaccine panel for the Food and Drug Administration (FDA) on Tuesday voted in favor of recommending updated COVID-19 vaccines specifically designed to combat the omicron variant. 

Several members of the vaccine panel reasoned that the likely benefits of an omicron-specific vaccine — possibly a bivalent shot — outweighed the possible risks. 

Still some debate: During the meeting, however, members brought up several possible points of contention regarding the recommendation. 

Some members argued that approaching the COVID-19 pandemic like it was the flu with seasonal boosters was not the right path, pointing out that the SARS-CoV-2 virus has been shown to mutate faster than the influenza virus. 

Read more here.

WHAT WE’RE READING

STATE BY STATE

OP-EDS IN THE HILL

That’s it for today, thanks for reading. Check out The Hill’s Health Care page for the latest news and coverage. See you tomorrow.

READ THE FULL VERSION HERE